Learning Objectives:

  1. Review data for continuous glucose monitoring (CGM) use in populations with diabetes and currently available systems
  2. Optimize successful use of CGM for patients and clinicians through:
    1. Review practical steps of prescribing and using CGM
    2. Understand components of CGM data reports and interpretation in clinical practice
  3. Consider the role of CGM in the diabetes technology ecosystem 

 

Speaker: 

Kathryn Fantasia, MD, MSC, Presenter has stock in Eli Lilly and Company and receives research grants from Novo Nordisk

 
Session date: 
11/26/2024 - 12:00pm to 1:00pm EST
Location: 
Boston Medical Center
850 Harrison Ave
Boston, MA 02118
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Participation
Please login or register to take this course.